SINTX Technologies Inc Total Liabilities
SINTX Technologies Inc total liabilities. Based on the latest financial reports, SINTX Technologies Inc (SINT) has total liabilities worth $7.30 Million USD as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check SINTX Technologies Inc asset resilience ratio to evaluate the company's liquid asset resilience ratio.
Total Liabilities of SINTX Technologies Inc (2011–2024)
Total liabilities of SINTX Technologies Inc from 2011 to 2024. This chart illustrates how SINTX Technologies Inc's total liabilities have evolved over time, based on quarterly financial data. Explore SINTX Technologies Inc (SINT) long-term investment share to see how much of total assets are deployed in long-term investments.
SINTX Technologies Inc Competitors by Total Liabilities
The table below lists competitors of SINTX Technologies Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
First Media Tbk
JK:KBLV
|
Indonesia | Rp1.44 Trillion |
|
Silynxcom Ltd.
NYSE MKT:SYNX
|
USA | $2.90 Million |
|
ChoA Pharmaceutical Co.Ltd
KQ:034940
|
Korea | ₩41.51 Billion |
|
Shanghai Taihe Water Environmental Technology Development Co Ltd
SHG:605081
|
China | CN¥424.21 Million |
|
Max Resource Corp
V:MAX
|
Canada | CA$2.13 Million |
|
Redsense Medical AB
ST:REDS
|
Sweden | Skr3.89 Million |
|
RED LIGHT HOLLAND CORP.
F:4YX
|
Germany | €3.82 Million |
|
Pollen Street PLC
LSE:POLN
|
UK | GBX228.92 Million |
Liability Composition Analysis (2011–2024)
This chart breaks down SINTX Technologies Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see SINTX Technologies Inc total assets.
Liquidity & Leverage Metrics
SINTX Technologies Inc Total Liabilities Ratios Explained
SINTX Technologies Inc total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.70 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.79 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.64 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how SINTX Technologies Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for SINTX Technologies Inc (2011–2024)
The table below shows the annual total liabilities of SINTX Technologies Inc from 2011 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | $5.52 Million | -16.29% |
| 2023-12-31 | $6.59 Million | -34.52% |
| 2022-12-31 | $10.07 Million | +116.77% |
| 2021-12-31 | $4.64 Million | +0.04% |
| 2020-12-31 | $4.64 Million | +17.69% |
| 2019-12-31 | $3.94 Million | +26.60% |
| 2018-12-31 | $3.12 Million | -66.13% |
| 2017-12-31 | $9.20 Million | -22.62% |
| 2016-12-31 | $11.89 Million | -46.50% |
| 2015-12-31 | $22.22 Million | -45.37% |
| 2014-12-31 | $40.68 Million | -78.29% |
| 2013-12-31 | $187.39 Million | +3.11% |
| 2012-12-31 | $181.74 Million | +3.55% |
| 2011-12-31 | $175.50 Million | -- |
About SINTX Technologies Inc
Sintx Technologies, Inc., an advanced ceramics company, engages in the research, development, and commercialization of medical devices manufactured with silicon nitride for biomedical, technical, and antipathogenic applications in the United States. The company offers solid and porous silicon nitride; silicon nitrite powder; and silicon nitride coating products, as well as silicon nitride composi… Read more